Shuganjieyu capsule for major depressive disorder (MDD) in adults: a systematic review

References

• Almeida, R.N., Navarro, D.S., de Assis, T.S., de Medeiros, I.A., & Thomas, G. (1998). Antidepressant effect of an ethanolic extract of the leaves of Cissampelos sympodialis in rats and mice. Journal of Ethnopharmacology, 63, 247–252.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (DSM-III) (3rd ed.). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (DSM-III-R) (3rd ed.). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (DSM-IV) (4th ed.). Washington, DC: American Psychiatric Publishing.
   Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-V) (5th ed.). Arlington, TX: American Psychiatric Publishing.
   Google Scholar
• Annick, L.P., & Thérèse, L. (1999). Prévalence et prise en charge médicale de la depression [Prevalence and medical treatment of depression]. Paris: CREDES.
   Google Scholar
• Brunoni, A.R., Lopes, M., Kaptchuk, T.J., & Freni, F. (2009). Placebo response of non-pharmacological and pharmacological trials in major depression: A systematic review and meta-analysis. PLoS One, 4(3), e4824.
   PubMed Web of Science ®Google Scholar
• Butler, L., & Pilkington, K. (2013). Chinese herbal medicine and depression: The research evidence. Evidence-Based Complementary and Alternative Medicine, 2013, 739716.
   Google Scholar
• Commission Nationale de Pharmacopée France [French Pharmacopoeia Commission]. (1982). Pharmacopée française [French pharmacopoeia] (10th ed.). Paris.
   Google Scholar
• Di, W., Zhaoxia, X., & Zhonghui, Z. (2012). Clinical analysis of Shugan-jieyu capsule in treatment of depression. China Journal Practical Medicine, 7, 26–27.
   PubMedGoogle Scholar
• Emsr, E. (1995). St. John's Wort, an antidepressant? A systematic, criteria-based review. Phytomedicine, 2(1), 67–71.
   PubMed Web of Science ®Google Scholar
• Gaster, B., & Holroyd, J. (2000). St. John's wort for depression. Archives of Internal Medicine, 160, 152–156.
   PubMed Web of Science ®Google Scholar
• Goldman, L.S., Nielsen, N.H., & Champion, H.C. (1999). Awareness, diagnosis and treatment of depression. Journal of General Internal Medicine, 14(9), 569–589.
   PubMed Web of Science ®Google Scholar
• Helmut Woelk for the Remotiv/Imipramine Study Group. (2000). Comparison of St. John's wort and imipramine for treating depression: Randomised controlled trial. BMJ, 321, 536–539.
   PubMed Web of Science ®Google Scholar
• Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., & McQuay, H.J. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17(1), 1–12.
   PubMedGoogle Scholar
• Jihua, T., Gaohua, W., & Xueguang, B. (2005). Combining acanthopanacis senticosus and lithium carbonate in the treatment of adolescent bipolar depression. Chinese Mental Health Journal, 19, 480–482.
   Google Scholar
• Jinhua, F., Yong, L., Qingyong, W., & Jingping, Z. (2012). Effect of Shuganjieyu capsules on neuronal apoptosis in hippocampal CA3 area and the expression of caspase-3 in the brain of rat depression model. Journal of Central South University, 37, 1198–1204.
   Google Scholar
• Jorm, A.F., Korten, A.E., Jacomb, P.A., Christensen, H., Rodgers, B., & Pollitt, P. (1997). Mental health literacy: A survey of the public's ability to recognize mental disorders and their belief about the effectiveness of treatment. Medical Journal of Australia, 166, 182–186.
   PubMed Web of Science ®Google Scholar
• Jorm, A.F., Medway, J., Christensen, H., Korten, A.E., Jacomb, P.A., & Rodgers, B. (2000). Public beliefs about the helpfulness of interventions for depression: Effects on actions taken when experiencing anxiety and depression symptoms. Australia and New Zealand Journal of Psychiatry, 34, 619–626.
   PubMed Web of Science ®Google Scholar
• Julian, P.T.H., & Sally, G. (2011). Cochrane handbook for systematic review of interventions version 5.1.0. Chichester: John Wiley & Sons, Ltd.
   Google Scholar
• Kai, T., Qinghong, Y., Zhibin, C., & Shujiao, L. (2012). A controlled trial of Shuganjieyu capsule combined venlafaxine for depression. Hebei Medical Journal, 34, 881–882.
   Google Scholar
• Kessler, R.C., Soukup, J., Davis, R.B., Foster, D.F., Wilkey, S.A., Van Rompay, M.I., & Eisenberg, D.M. (2001). The use of complementary and alternative therapies to treat anxiety and depression in the United States. American Journal of Psychiatry, 158(2), 289–294.
   PubMed Web of Science ®Google Scholar
• Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., & Johnson, B.T. (2008). Initial severity and anti-depressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), 260–267.
   Web of Science ®Google Scholar
• Klaus, L., Gilbert, R., Cynthia, D.M., Andrej, P., Wolfgang, W., & Dieter, M. (1996). St John's wort for depression-an overview and meta-analysis of randomised clinical trials. BMJ, 313, 253–258.
   PubMed Web of Science ®Google Scholar
• Klaus, L., Michael, B., Matthias, E., & Cynthia, M. (2005). St John's wort for depression: Meta-analysis of randomised controlled trials. British Journal of Psychiatry, 186, 99–107.
   PubMed Web of Science ®Google Scholar
• Liji, J., Feifei, W., Xiaoyu, L., Huaqiang, L., Chong, D., Qi, J., … Yongping, X. (2013). Anti-depressant effects of aqueous extract from Acanthopanax senticosusin mice. Phytotherapy Research, 27(12), 1829–1833.
   Web of Science ®Google Scholar
• Luo, L., Wang, J.N., Kong, L.D., Jiang, Q.G., & Tan, R.X. (2000). Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. Journal of Ethnopharmacology, 73, 277–281.
   PubMed Web of Science ®Google Scholar
• McCrone, P., Dhanasiri, S., & Patel, A. (2008). Paying the price: The cost of mental health care in England to 2026. London: King's Fund.
   Google Scholar
• Müller, W.E., Rolli, M., Schafer, C., & Hafner, U. (1997). Effects of hypericum extract (LI 160) in bio-chemical models of antidepressant activity. Pharmacopsychiatry, 30, 102–107.
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health. (1985). Treatment emergent symptoms scale-write-in (TESS). Psychopharmacology Bulletin, 21, 1069–1073.
   Web of Science ®Google Scholar
• Nianwen, S., Emily, D., Amelito, T., Zhun, C., & Michael, H. (2012). Predictors of treatment with duloxetine or venlafaxine XR among adult patients treated for depression in primary care practices in the United Kingdom. Depression Research and Treatment, 2012, 815363.
   Google Scholar
• Norman, G.R. (1989). Issues in the use of change scores in randomized trials. Journal of Clinical Epidemology, 42, 1097–1105.
   PubMed Web of Science ®Google Scholar
• Psychiatry Branch of Chinese Medical Association. (2001). Category and diagnostic criteria of mental disorder of China (3rd ed.). Jinan: Shandong Science and Technology Press.
   Google Scholar
• Qian, T., & Youlin, L. (2011). Traditional Chinese medicine research and analysis on the treatment of depression. Journal of Practical Traditional Chinese Internal Medicine, 25, 41–42.
   Google Scholar
• Richard, C.S., Martin, B.K., Alan, G., David, L.D., Robert, H., & Michael, E.T. (2001). Effectiveness of St John's wort in major depression. A randomized controlled trial. JAMA, 285(15), 1978–1986.
   PubMed Web of Science ®Google Scholar
• Richard, N., & Osmaan, S. (2011). Complementary and alternative medicine for the treatment of major depressive disorder. Canadian Family Physician, 57, 660–663.
   Google Scholar
• Ross, S.M. (2010). Mild to moderate depression: A complementary and integrative therapies approach. Holistic Nursing Practice, 24(5), 303–309.
   PubMedGoogle Scholar
• Schulz, K.F., Altman, D.G., & Moher, D. (2011). Consort 2010 statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine, 154, 291–292.
   Web of Science ®Google Scholar
• Singleton, N., Bumpstead, R., & Brien, M.O. (2001). Psychiatric morbidity among adults living in private households 2000. London: The Stationery Office.
   Google Scholar
• Sithisarn, P., Rojsanga, P., Jarikasem, S., Tanaka, K., & Matsumoto, K. (2013). Ameliorative effects of Acanthopanax trifoliatus on cognitive and emotional deficits in Olfactory Bulbectomized mice: An animal model of depression and cognitive deficits. Evidence-Based Complementary and Alternative Medicine, 2013, 701956.
   Google Scholar
• Stahl, S.M., Grady, M.M., Moret, C., & Briley, M. (2005). SNRIs: Their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectrums, 10, 732–747.
   PubMed Web of Science ®Google Scholar
• Suzuki, O., Katsumata, Y., Oya, M., Bladt, S., & Wagner, H. (1984). Wagner inhibition of monoamine oxidase by hypericin. Planta Medica, 50, 272–274.
   PubMed Web of Science ®Google Scholar
• Thomas, C., & Morris, S. (2003). Cost of depression among adults in England in 2000. British Journal of Psychiatry, 183, 154–159.
   Web of Science ®Google Scholar
• Ware, J.E., Kosinski, M., & Keller, S.D. (1994). SF36 physical and mental health summary scales: A user's manual. Boston, MA: Health Institute, New England Medical Centre.
   Google Scholar
• Weissman, M.M., Bland, R.C., & Canino, G.J. (1996). Cross national epidemiology of major depression and bipolar disorder. JAMA, 27, 293–299.
   Google Scholar
• Weng, S.H., Tang, J.H., Wang, G.H., & Wang, X.P. (2007). Double-blind comparison of addition of Acanthopanax senticosus versus fluoxetine to lithium for treatment of adolescent patients with bipolar depression. European Psychiatry, 22, S261–S262.
   Web of Science ®Google Scholar
• World Health Organization. (1978). The ninth revision of the international classification of diseases and related health problems (ICD-9) (9th ed.). Geneva: World Health Organization.
   Google Scholar
• World Health Organization. (1992). The tenth revision of the international classification of diseases and related health problems (ICD-10) (10th ed.). Geneva: World Health Organization.
   Google Scholar
• Xinyu, S., Aiqin, C., Xiufeng, X., Honggen, Z., Qisheng, T., & Hongyan, Z. (2009). Randomized, double-blind, placebo-controlled trial of Shuganjieyu capsule in the treatment of mild or moderate depression. Chinese Journal of New Drugs, 18, 413–457.
   Google Scholar
• Xu, C., Luo, L., & Tan, R.X. (2004). Antidepressant effect of three traditional Chinese medicines in the learned helplessness model. Journal of Ethnopharmacology, 91(2–3), 345–349.
   PubMed Web of Science ®Google Scholar
• Yajun, W. (2011). Shuganjieyu capsule plus venlafaxine in the treatment of depression. Journal of China Traditional Chinese Medicine Information, 3, 194.
   Google Scholar
• Yan, B., Hongyan, J., Xiufeng, X., & Shanshan, L. (2011). Clinical trials for Anjiaxin Capsule to treat depression (stagnation of liver-qi with deficiency of the spleen syndrome). Chinese Traditional Patent Medicine, 33, 17–21.
   Google Scholar